Home
Home

Allos

2012 Biotech Stock Predictions: An Interim Report Card

2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire

Keryx: A Lot Can Go Wrong At $2

Keryx: A Lot Can Go Wrong At $2
Seeking Alpha

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics

Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire

Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade

Bio-Pharma Catalyst Trades And ASCO Movers: Making The Grade
Seeking Alpha

Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth

Second Physician Survey Supports Prescription Data: Expecting 1Q Fusilev Growth
Seeking Alpha

Allos to be acquired by Spectrum Pharma for $206M

Allos to be acquired by Spectrum Pharma for $206M
Marketwatch

Upcoming ASCO Meeting Could Move These Stocks

Upcoming ASCO Meeting Could Move These Stocks
Seeking Alpha

Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek

Allos Therapeutics Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet